SLNO NASDAQ
Soleno Therapeutics, Inc.
1W: +0.1%
1M: +0.4%
3M: +37.7%
YTD: +12.4%
1Y: -29.4%
3Y: +152.4%
5Y: -32.7%
$53.01
Last traded 2026-05-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$285M
Revenue
+0.0% YoY
$96M
Net Income
+148.5% YoY
$106M
Free Cash Flow
+217.9% YoY
98.7%
Gross Margin
33.6%
Op. Margin
33.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE26.4%
ROA20.7%
ROIC34.6%
Valuation
P/E27.1
P/B5.6
EV/EBITDA14.3
Leverage
Debt/Equity0.01
Current Ratio5.62
Interest Cov.19.4x
Quality Scores
Piotroski F6/9
Altman Z10.11
Beneish M0.00